prof. dr. K. (Klaas) Poelstra

Professor

Research

Postal address:
A Deusinglaan1
Gebouw 5161, ruimte 0509
9713 AV
Groningen
Netherlands
Phone: +31 50 363 7721Fax: +31 50 363 3247
  1. 2011
  2. Brands, R., & Poelstra, K. (2011). IPC No. A61K38/46. Means and methods for treating and/or preventing necrotizing enterocolitis. Manuscript submitted for publication. (Patent No. US2011142817).
  3. 2010
  4. Poelstra, K., Prakash, J., Beljaars, L., & Bansal, R. (2010). IPC No. 20130064791. Interferon Analogs. (Patent No. 20130064791).
  5. Moreno, M., Gonzalo, T., Kok, R. J., Sancho-Bru, P., van Beuge, M., Swart, J., ... Bataller, R. (2010). Reduction of Advanced Liver Fibrosis by Short-Term Targeted Delivery of an Angiotensin Receptor Blocker to Hepatic Stellate Cells in Rats. Hepatology, 51(3), 942-952. https://doi.org/10.1002/hep.23419
  6. Chen, K. T., Malo, M., Beasley-Topliffe, L. K., Poelstra, K., Millan, J., Mostafa, G., ... Hodin, R. A. (2010). A role for intestinal alkaline phosphatase in the maintenance of local gut immunity. Journal of Surgical Research, 158(2), 258-259. https://doi.org/10.1007/s10620-010-1396-x
  7. 2009
  8. Tuin, A., Poelstra, K., de Jager-Krikken, A., Raaben, W., Velders, M. P., & Dijkstra, G. (2009). Role of alkaline phosphatase in colitis in man and rats. Gut, 58(3), 379-387. https://doi.org/10.1136/gut.2007.128868
  9. 2008
  10. Poelstra, K., Beljaars, E., Meijer, D., & Schuppan, D. (2008). IPC No. A61K38/12. Peptide-based carrier devices for stellate cells. Manuscript submitted for publication. (Patent No. US2008267877).
  11. 2007
  12. Serriere-Lanneau, V., Teixeira-Clerc, F., Li, L., Schippers, M., de Wries, W., Julien, B., ... Lotersztajn, S. (2007). The sphingosine 1-phosphate receptor S1P(2) triggers hepatic wound healing. The FASEB Journal, 21(9), 2005-2013. https://doi.org/10.1096/fj.06-6889com
  13. 2006
  14. Beljaars, L., Meijer, D., & Poelstra, K. (2006). Drug targeting to hepatic stellate cells: a new strategy to treat liver fibrosis. Chapter 25. In S. Ali, S. L. Friedman, & D. A. Mann (Eds.), Liver Diseases. Biochemical mechanisms and new therapeutic insights.: Vol. 2 Pathophysiology, diagnostic and therapeutic insights (Vol. 2, pp. 459-474). New Hampshire, USA: Science Publishers.
  15. 2005
  16. Brands, R., & Poelstra, K. (2005). IPC No. A61K38/46; A61P37/02. Use of alkaline phosphatase for the detoxification of LPS present at mucosal barriers. Manuscript submitted for publication. (Patent No. CA2847517).
  17. Prakash, J., van Loenen - Weemaes, A., Haas, M., Proost, J. H., Meijer, D. K. F., Moolenaar, F., ... Kok, R. J. (2005). Renal-selective delivery and angiotensin-converting enzyme inhibition by subcutaneously administered captopril-lysozyme. Drug Metabolism and Disposition, 33(5), 683-688. https://doi.org/10.1124/dmd.104.002808

ID: 128486